Skip to main content
OpenTrials
Completed

NCT Number: NCT06325865

Perception of Unpleasant Sensations During Study Procedures in ALS Patients

Diagnosis of Amyotrophic Lateral Sclerosis (ALS) is considered a traumatic life event for both the patient and their next-of-kin/carers, due to the lack of treatment. Clinical Trials can offer pioneering treatment to reduce the impact of the disease and improve future treatments worldwide. Research protocols may involve routine diagnostic and/or therapeutic procedures which the patients may be already aware of and, therefore, expecting specific sensations. These could compromise participation or drop-out rate. Despite everything, participation in a clinical trial can guarantee continuity of care also thanks to the execution of these same procedures, through preferential access compared to other patients.

Aim of this study is to investigate the unpleasant sensations perceived by ALS patients during procedures in clinical trials. Analysing what type of pain/discomfort frightens patients during diagnostic and/or therapeutic procedures, including the different methods of administration of the study drug. Provide data to implement effective therapy and offer constant patients support throughout ALS specific and needed procedures. Evaluate if this support could influence adherence rate of ALS patients to conduct clinical trials as required. Provide information for future studies to create an ALS Clinical Trials multiple-retention-factors adherence scale. Create and implement an ALS-specific pain scale accounting for its impact on daily activities, aiding an interdisciplinary approach of pain management. Identify the best pain management strategies and compliance techniques to address ALS, not merely in clinical trials. Provide the best individualized care for ALS patients improving their quality of life and mental state.

This is a descriptive phenomenological study and data will be analyzed according to Sundler's method. Based on the experience of the researchers and the recommendations proposed by Sandelowski, a total of 20 interviews are estimated in order to reach the theoretical saturation per category of reference. Data collection will be carried out through in-depth semi-structured interviews recorded (13 open-ended questions after the execution of the procedures).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Istituto Auxologico italiano IRCSS, San Luca Hospital

Milan, 20145, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Spinal or bulbar Amyotrophic Lateral Sclerosis (ALS)
  • Age > 18 years
  • Adequate understanding of Italian language
  • Full understanding of the study
  • Informed consent signed
  • Current or past participation in interventional clinical studies
  • Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) score of item # 4 ≥ 2, or score of item #1 ≥ 1

Exclusion criteria

  • Clinically relevant cognitive dysfunction
  • Inability to answer orally or by writing to the questions of the interview
  • Hospital Anxiety and Depression Scale (HADS) scale ≥ 11

Treatment and study plan

interview

Other

Interview with ALS patient in which the experiences of unpleasant sensations or pain during study procedures are assessed in a qualitative manner.

Primary outcomes

  1. Prevalence of experience of unpleasant sensations or pain

    Time frame: At enrollment

    Prevalence of reported experience of unpleasant sensations orn pain during study procedures

  2. Study procedure that causes unpleasant sensations or pain

    Time frame: At enrollment

    Qualitative description of study procedure that causes unpleasant sensations or pain

  3. Duration of unpleasant sensations or pain caused by the study procedure

    Time frame: At enrollment

    Duration in minutes of unpleasant sensations or pain caused by the study procedure

Secondary outcomes

  1. HADS score

    Time frame: At enrollment

    Score on Hospital Anxiety and Depression Scale (HADS) scale

  2. ALSFRS score

    Time frame: At enrollment

    Score on Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) scale

Sponsors and collaborators

Lead sponsor

Istituto Auxologico Italiano

Other

Registry information

Official study title

Perception of Unpleasant Sensations in Patients With Amyotrophic Lateral Sclerosis During Procedures Performed in Clinical Trials

Acronym: PESALS

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Mar 22, 2024
Registry last updated
Nov 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.